Bremen, May 27, 2020 - MeVis Medical Solutions AG [ISIN: DE000A0LBFE4], a leading provider of medical imaging software, today announces its results for the first half of fiscal year 2019/2020, reporting period October 1, 2019 to March 31, 2020.
Revenues generated in the first half of the year amounted to € 8,677 k, only about 2 % below the previous year's level (prev. year: € 8,815 k). 31 % (prev. year: 27 %) of revenues were attributable to the sale of licenses, 40 % (prev. year: 39 %) to maintenance revenues and 29 % (prev. year: 34 %) to other revenues, which include services provided to and charged to affiliated companies and the parent company.
Earnings before interest and taxes (EBIT) fell from € 3,978 k to € 2,937 k, corresponding to an EBIT margin of 34 %, mainly as a result of lower revenues compared to the previous year, increased personnel expenses and higher other operating expenses, adjusted for exchange rate losses.
The company's net interest result amounts to € 85 k (previous year: € 84 k). This results in earnings before taxes (EBT) of € 3,022 k (prev. year: € 4,062 k).
In the past half-year, income taxes of € 42 k (prev. year: € 0 k) were incurred. Taking into account the expense of € 2,980 thousand (previous year: € 4,062 k) from the profit to be transferred to Varex Imaging Deutschland AG, net income for the year amounted to € 0 k (previous year: € 0 k).
"Looking at the figures, the first half-year was again successful for MeVis," said Marcus Kirchhoff, CEO of MeVis Medical Solutions AG. "A topic which has also been on our minds since mid-March, has a major impact on our day-to-day work and poses particular challenges for us is the spread of the coronavirus (COVID-19). We assume that the corona pandemic will have a significant impact on the global economy and the German economy. The effects for MeVis Medical Solutions AG cannot be foreseen or assessed at this time. For this reason, we are currently sticking to our forecast: for the 2019/2020 fiscal year, we expect a substantial decline in revenues to € 15.5 million to 16.0 million. We expect earnings before interest and taxes (EBIT) to decline to between € 4.5 million and € 5.0 million.”